A detailed history of Sage View Advisory Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sage View Advisory Group, LLC holds 8,949 shares of NVO stock, worth $963,180. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,949
Holding current value
$963,180
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $1.1 Million - $1.31 Million
8,949 New
8,949 $1.28 Billion
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $218,484 - $262,465
2,489 New
2,489 $271 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sage View Advisory Group, LLC Portfolio

Follow Sage View Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage View Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage View Advisory Group, LLC with notifications on news.